MA H1703

Bill

Relative to opioid drug manufacturer assessments

Introduced
01/22/2019

In Committee
01/22/2019

Crossed Over

Passed

Dead
12/31/2020

Introduced Session

191st General Court

Bill Summary

Relative to opioid drug manufacturer assessments. Mental Health, Substance Use and Recovery.

AI Summary

This bill establishes a new assessment on opioid drug manufacturers in Massachusetts. The assessment would be based on the ratio of each manufacturer's annual distribution and dispensing of opioid drugs in the state compared to the total statewide distribution and dispensing. The total annual assessment would not exceed $15 million, and the funds would go to the Opioid Treatment and Addiction Prevention Fund to support prevention, treatment, management, and research related to opioid addiction and alternative pain management. The Department of Public Health is required to promulgate regulations to implement the assessment within 180 days, and the assessment will take effect on June 30, 2020.

Committee Categories

Health and Social Services

Sponsors (22)

Michael Brady (D), Gerry Cassidy (D), Claire Cronin (D), Josh Cutler (D), Shawn Dooley (R), Carolyn Dykema (D), Lori Ehrlich (D), Tricia Farley-Bouvier (D), Carole Fiola (D), Bill Galvin (D), Randy Hunt (R), Louis Kafka (D), Hannah Kane (R), Rady Mom (D), Brian Murray (D), Jim O'Day (D), Sarah Peake (D), Smitty Pignatelli (D), Dave Rogers (D), Jeff Roy (D), Aaron Vega (D), Bud Williams (D),

Last Action

Accompanied a new draft, see H4532 (on 03/09/2020)

Official Document

https://malegislature.gov/Bills/191/H1703

(10 Companion Bills)

Version:

Document Type	Source Location
State Bill Page	https://malegislature.gov/Bills/191/H1703
Bill	https://malegislature.gov/Bills/191/H1703.pdf

Bill	Bill Name	Last Action	Type
H126	Relative to early intervention services for children with prenatal exposure to opioids	Accompanied a new draft, see H4489	Similar To
H1717	Advancing public health and safety using fentanyl testing strips	Accompanied a study order, see H4450	Similar To
H1747	Helping overdosing persons in emergencies	Accompanied a new draft, see H4538	Similar To
H4532	Relative to opioid drug manufacturer assessments	Reporting date extended to Thursday December 31, 2020, pending concurrence	Replaced by
S1087	Raising employment and combating opioids through vocational education and rehabilitation (RECOVER)	Accompanied a study order, see S2550	Similar To
S1149	Strengthening prescription drug safety and drug stewardship	Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session	Similar To
S1160	Expanding access to patient centered care for opioid use disorder	Accompanied a study order, see S2888	Similar To
S1168	Relative to informing opioid patients about the risks of addiction	Accompanied a study order, see S2550	Similar To
S1277	Relative to the prescription monitoring program	Accompanied a study order, see S2683	Similar To
S303	Relative to prescription opioid abuse prevention education	Accompanied a study order, see S2538	Similar To

Bill > H1703

MA H1703

summary

Introduced Session

Bill Summary

AI Summary

Committee Categories

Sponsors (22)

Last Action

Official Document

bill text

bill summary

bill summary

bill summary